Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Mar 31;16(3):e0248423.
doi: 10.1371/journal.pone.0248423. eCollection 2021.

Assessing pregnancy and neonatal outcomes in Malawi, South Africa, Uganda, and Zimbabwe: Results from a systematic chart review

Affiliations

Assessing pregnancy and neonatal outcomes in Malawi, South Africa, Uganda, and Zimbabwe: Results from a systematic chart review

Jennifer E Balkus et al. PLoS One. .

Abstract

A systematic chart review was performed to estimate the frequency of pregnancy outcomes, pregnancy complications and neonatal outcomes at facilities in Blantyre, Malawi; Johannesburg, South Africa; Kampala, Uganda; and Chitungwiza and Harare, Zimbabwe to provide comparisons with estimates from an ongoing clinical trial evaluating the safety of two biomedical HIV prevention interventions in pregnancy. A multi-site, cross-sectional chart review was conducted at Maternal Obstetric Units and hospitals where women participating in the ongoing clinical trial would be expected to deliver. All individuals delivering at the designated facilities or admitted for postpartum care within seven days of a delivery elsewhere (home, health clinic, etc.) were included in the review. Data were abstracted for pregnancy outcomes, pregnancy complications, maternal and neonatal death, and congenital anomalies. Data from 10,138 records were abstracted across all four sites (Blantyre n = 2,384; Johannesburg n = 1,888; Kampala n = 3,708; Chitungwiza and Harare n = 2,158), which included 10,426 pregnancy outcomes. The prevalence of preterm birth was 13% (range across sites: 10.4-20.7) and 4.1% of deliveries resulted in stillbirth (range: 3.1-5.5). The most commonly noted pregnancy complication was gestational hypertension, reported among 4.4% of pregnancies. Among pregnancies resulting in a live birth, 15.5% were low birthweight (range: 13.8-17.4) and 2.0% resulted in neonatal death (range:1.2-3.2). Suspected congenital anomalies were noted in 1.2% of pregnancies. This study provides systematically collected data on background rates of pregnancy outcomes, pregnancy complications and neonatal outcomes that can be used as a reference in support of ongoing HIV prevention studies. In addition, estimates from this study provide important background data for future studies of investigational products evaluated in pregnancy in these urban settings.

PubMed Disclaimer

Conflict of interest statement

The authors have declared that no competing interests exist.

Figures

Fig 1
Fig 1. Frequency of pregnancy outcomes by site.
Data on pregnancy outcomes, overall and by site, for n = 10,180 pregnancy outcomes. Records where the pregnancy outcome could not be ascertained were excluded.
Fig 2
Fig 2. Frequency of pregnancy complications by country.
Data presented, overall and by site, for n = 10,138 records reviewed. Data on pregnancy-related compilations were missing from <1% of records.
Fig 3
Fig 3. Pregnancy outcomes and complications by maternal HIV status.
Data presented by maternal HIV status for n = 10,017 individuals where HIV status was documented in the chart.

References

    1. UNAIDS. Global AIDS Update 2019. https://wwwunaidsorg/sites/default/files/media_asset/2019-global-aids-up...; accessed 20 July 2020.
    1. Drake AL, Wagner A, Richardson B, John-Stewart G. Incident HIV during pregnancy and postpartum and risk of mother-to-child HIV transmission: a systematic review and meta-analysis. PLoS Med. 2014;11(2):e1001608. Epub 2014/03/04. 10.1371/journal.pmed.1001608 . - DOI - PMC - PubMed
    1. Baeten JM, Palanee-Phillips T, Brown ER, Schwartz K, Soto-Torres LE, Govender V, et al.. Use of a Vaginal Ring Containing Dapivirine for HIV-1 Prevention in Women. N Engl J Med. 2016;375(22):2121–32. Epub 2016/02/24. 10.1056/NEJMoa1506110 . - DOI - PMC - PubMed
    1. Nel A, van Niekerk N, Kapiga S, Bekker LG, Gama C, Gill K, et al.. Safety and Efficacy of a Dapivirine Vaginal Ring for HIV Prevention in Women. N Engl J Med. 2016;375(22):2133–43. Epub 2016/12/14. 10.1056/NEJMoa1602046 . - DOI - PubMed
    1. Network HPT. HPTN 083 Study Demonstrates Superiority of Cabotegravir for the Prevention of HIV. https://wwwhptnorg/news-and-events/press-releases/hptn-083-study-demonst...; accessed 20 July 2020.

Publication types

MeSH terms